Cost-minimisation analysis of erlotinib in the second-line...

Cost-minimisation analysis of erlotinib in the second-line treatment of non-small-cell lung cancer: a Brazilian perspective

Doral Stefani, Stephen, Giorgio Saggia, Mario, Vicino dos Santos, Eduardo Augustus
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.3111/13696990802208186
Date:
September, 2008
File:
PDF, 614 KB
english, 2008
Conversion to is in progress
Conversion to is failed